chitinas
protein
human
breast
regress
protein
brp
mice
requir
optim
allergen
sensit
inflamm
variou
chronic
inflammatori
diseas
includ
asthma
howev
role
airway
inflamm
induc
respiratori
virus
investig
aim
studi
investig
relationship
airway
inflamm
caus
respiratori
syncyti
viru
rsv
infect
measur
level
human
nasopharyng
aspir
npa
hospit
children
present
acut
respiratori
symptom
wildtyp
wt
knockout
ko
mice
inocul
live
rsv
strain
bronchoalveolar
lavag
fluid
lung
tissu
sampl
obtain
day
inocul
assess
lung
inflamm
airway
reactiv
express
cytokin
human
subject
level
npa
higher
children
rsv
infect
control
subject
express
cytokin
particular
increas
follow
rsv
infect
mice
airway
inflamm
caus
rsv
infect
reduc
ko
mice
compar
wt
mice
cytokin
level
increas
lung
rsvinfect
ko
mice
regul
macrophag
activ
rsvinfect
mice
addit
treatment
antibodi
attenu
airway
inflamm
cytokin
product
rsvinfect
wt
mice
find
suggest
could
contribut
airway
inflamm
induc
rsv
infect
could
potenti
therapeut
candid
attenu
immunopatholog
rsv
infect
bronchiol
chitinas
protein
lower
respiratori
tract
infect
respiratori
syncyti
virus
type
immun
respiratori
syncyti
viru
rsv
viru
commonli
associ
bronchiol
affect
infant
young
children
induc
lower
respiratori
tract
ill
lrti
encompass
bronchiol
viral
pneumonia
lead
death
sever
case
children
infect
rsv
age
year
nearli
half
case
experi
recurr
infect
larg
proport
young
patient
rsv
bronchiol
recurr
episod
lower
airway
obstruct
may
continu
year
acut
infect
resolv
sever
prospect
birth
cohort
studi
report
earlylif
rsvassoci
lrti
play
import
caus
role
pathogenesi
recurr
wheez
asthma
howev
current
therapeut
option
limit
support
treatment
focus
fluid
respiratori
mainten
need
wide
avail
costeffect
prevent
measur
addit
mechan
rsv
evad
host
defens
fulli
understood
clarifi
rsv
pathogenesi
human
develop
prophylact
therapeut
strategi
rsv
infect
respiratori
tract
requir
recent
chitinas
protein
human
breast
regress
protein
brp
mice
implic
develop
asthma
circul
level
increas
patient
asthma
correl
diseas
sever
variant
affect
serum
level
influenc
asthma
statu
lung
function
identifi
import
regul
allerg
respons
tissu
remodel
mice
also
link
type
chronic
lung
inflamm
acut
lung
injuri
howev
role
viral
respiratori
infect
previous
investig
studi
hypothes
involv
airway
inflamm
induc
rsv
infect
investig
possibl
measur
human
nasopharyng
aspir
npa
hospit
children
present
acut
respiratori
symptom
compar
immun
respons
induc
rsv
wildtyp
wt
knockout
ko
mice
found
rsv
infect
induc
immun
respons
murin
model
may
enhanc
airway
hyperrespons
ahr
inflammatori
cell
recruit
mucu
product
rsvinfect
mice
moreov
treatment
antibodi
attenu
rsvinduc
airway
inflamm
cytokin
product
rsvinfect
wt
mice
suggest
therapeut
candid
treatment
rsvassoci
lrti
decemb
februari
nasopharyng
aspir
collect
children
hospit
sever
respiratori
syncyti
viru
infect
induc
increas
express
macrophag
epitheli
cell
relat
inflamm
lack
attenu
rsvinduc
airway
inflamm
respons
import
regul
rsv
infect
suggest
potenti
therapeut
target
rsvrelat
respiratori
ill
children
hospit
due
acut
respiratori
symptom
cough
wheez
tachypnea
npa
collect
steril
suction
cathet
insert
oropharynx
nostril
gentl
suction
appli
use
electr
suction
pump
wash
cathet
normal
salin
sampl
place
viral
transport
medium
kept
pro
rsv
strain
propag
cell
american
type
cultur
collect
manassa
va
usa
harvest
day
postinfect
dpi
cytopath
effect
infect
cell
maxim
final
titer
also
establish
cell
determin
standard
plaqu
assay
lung
resist
measur
dpi
previous
describ
paraffinembed
section
lung
specimen
stain
hematoxylin
eosin
h
e
period
acidschiff
pa
assess
inflamm
mucu
product
respect
express
detect
ihc
use
human
cartilag
glycoprotein
protein
measur
elisa
previous
describ
lee
et
al
taqman
primerprob
set
gapdh
purchas
appli
biosystem
foster
citi
ca
usa
rel
mrna
level
determin
compar
method
rsv
quantif
known
concentr
rsv
use
gener
standard
curv
standard
neg
control
includ
pcr
assay
custom
taqman
primerprob
set
rsv
n
gene
wellconserv
region
rsv
use
gene
express
quantifi
use
stepon
realtim
pcr
system
appli
biosystem
whole
lung
mous
prepar
follow
previous
describ
assess
altern
macrophag
activ
alveolar
macrophag
balf
lung
cell
examin
surfac
express
arginas
activ
balf
lung
lysat
measur
use
quantichrom
arginas
assay
kit
bioassay
system
hayward
ca
usa
accord
manufactur
instruct
wt
rsvinfect
mice
administ
singl
dose
antibodi
r
system
vehicl
via
intraperiton
rout
hour
rsv
infect
mice
euthan
dpi
inflamm
immun
respons
induc
rsv
infect
analyz
chang
express
also
note
lung
harvest
group
stain
h
e
pa
evalu
inflamm
mucu
product
respect
baselin
characterist
patient
compar
mannwhitney
u
test
fisher
exact
test
appropri
correl
level
npa
determin
spearman
rank
correl
test
data
analyz
spss
softwar
spss
inc
chicago
il
usa
experiment
data
express
mean
sd
group
compar
unpair
student
test
anova
bonferroni
correct
appropri
use
prism
softwar
graphpad
inc
la
jolla
ca
usa
p
consid
statist
signific
investig
relationship
rsv
infect
level
npa
sampl
hospit
children
measur
figur
clinic
characterist
subject
summar
tabl
patient
rsv
infect
patient
without
confirm
pathogen
signific
differ
age
gender
durat
admiss
past
histori
laboratori
find
children
confirm
rsv
infect
show
higher
score
acut
respiratori
symptom
time
admiss
control
group
p
children
rsv
infect
higher
figur
compar
express
control
rsvinfect
mice
dpi
children
rsv
infect
level
lung
balf
increas
rsvinfect
compar
control
mice
figur
histolog
analysi
reveal
tissu
inflamm
figur
mucu
product
figur
f
also
decreas
rsvinfect
null
mice
differ
viral
load
rsv
infect
wt
ko
mice
figur
data
indic
loss
could
attenu
airway
inflamm
induc
rsv
infect
without
signific
chang
viral
load
effect
product
inflammatori
cytokin
next
investig
mechan
drive
inflamm
ahr
rsv
infect
mice
sinc
altern
activ
macrophag
known
affect
inflamm
rsv
infect
associ
allerg
inflamm
evalu
macrophag
activ
found
number
macrophag
balf
lung
cell
increas
infect
mice
figur
c
moreov
macrophag
arginas
activ
balf
figur
lung
lysat
figur
increas
infect
wt
ko
mice
although
lower
latter
result
indic
regul
accumul
activ
macrophag
induc
inflamm
rsv
infect
consist
data
decreas
rsvinduc
airway
inflamm
null
mice
evalu
therapeut
effect
antibodi
rsv
infect
found
singl
dose
antibodi
administ
wt
mice
intraperiton
inject
hour
rsv
infect
decreas
inflammatori
respons
figur
well
express
figur
f
rel
nontreat
wt
rsv
mice
histolog
examin
reveal
inflamm
figur
mucu
product
figur
also
decreas
antibodi
treatment
effect
viral
load
lung
figur
cytokin
level
also
decreas
mice
treat
antibodi
compar
control
group
show
greatest
reduct
figur
